» Articles » PMID: 24319650

Pathway Analyses and Understanding Disease Associations

Overview
Specialty Genetics
Date 2013 Dec 10
PMID 24319650
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

High throughput technologies have been applied to investigate the underlying mechanisms of complex diseases, identify disease-associations and help to improve treatment. However it is challenging to derive biological insight from conventional single gene based analysis of "omics" data from high throughput experiments due to sample and patient heterogeneity. To address these challenges, many novel pathway and network based approaches were developed to integrate various "omics" data, such as gene expression, copy number alteration, Genome Wide Association Studies, and interaction data. This review will cover recent methodological developments in pathway analysis for the detection of dysregulated interactions and disease-associated subnetworks, prioritization of candidate disease genes, and disease classifications. For each application, we will also discuss the associated challenges and potential future directions.

Citing Articles

CANDI: a web server for predicting molecular targets and pathways of cannabis-based therapeutics.

Ekambaram S, Wang J, Dokholyan N J Cannabis Res. 2025; 7(1):13.

PMID: 40016810 PMC: 11866588. DOI: 10.1186/s42238-025-00268-w.


CANDI: A Web Server for Predicting Molecular Targets and Pathways of Cannabis-Based Therapeutics.

Ekambaram S, Wang J, Dokholyan N Res Sq. 2024; .

PMID: 39149470 PMC: 11326374. DOI: 10.21203/rs.3.rs-4744915/v1.


Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways.

Yu L, Wang M, Yang Y, Xu F, Zhang X, Xie F PLoS Comput Biol. 2021; 17(2):e1008696.

PMID: 33561121 PMC: 7920387. DOI: 10.1371/journal.pcbi.1008696.


mitch: multi-contrast pathway enrichment for multi-omics and single-cell profiling data.

Kaspi A, Ziemann M BMC Genomics. 2020; 21(1):447.

PMID: 32600408 PMC: 7325150. DOI: 10.1186/s12864-020-06856-9.


De novo variants in exomes of congenital heart disease patients identify risk genes and pathways.

Sevim Bayrak C, Zhang P, Tristani-Firouzi M, Gelb B, Itan Y Genome Med. 2020; 12(1):9.

PMID: 31941532 PMC: 6961332. DOI: 10.1186/s13073-019-0709-8.


References
1.
Draghici S, Khatri P, Tarca A, Amin K, Done A, Voichita C . A systems biology approach for pathway level analysis. Genome Res. 2007; 17(10):1537-45. PMC: 1987343. DOI: 10.1101/gr.6202607. View

2.
Fernald G, Capriotti E, Daneshjou R, Karczewski K, Altman R . Bioinformatics challenges for personalized medicine. Bioinformatics. 2011; 27(13):1741-8. PMC: 3117361. DOI: 10.1093/bioinformatics/btr295. View

3.
Dutkowski J, Kramer M, Surma M, Balakrishnan R, Cherry J, Krogan N . A gene ontology inferred from molecular networks. Nat Biotechnol. 2012; 31(1):38-45. PMC: 3654867. DOI: 10.1038/nbt.2463. View

4.
Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M . A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004; 351(27):2817-26. DOI: 10.1056/NEJMoa041588. View

5.
Oti M, Ballouz S, Wouters M . Web tools for the prioritization of candidate disease genes. Methods Mol Biol. 2011; 760:189-206. DOI: 10.1007/978-1-61779-176-5_12. View